VENOMAID EXTENDS ITS SEED ROUND TO A TOTAL OF $ 1.8 M FOR AFFORDABLE AND RAPID SNAKEBITE DIAGNOSTICS

Contributed by: PR Newswire

Tags

VENOMAID-SeedRoundExt

More Like This

Diamyd Medical announces expanded financial support from Breakthrough T1D

Kindeva Drug Delivery awarded up to $129 million to supply DuoDote® autoinjectors to the Strategic National Stockpile

Diamyd Medical hits a recruitment milestone in DIAGNODE-3 Phase 3 trial

Recruitment milestone reached in Diamyd® Phase 3 trial

Business Wire logo

Kindeva Global Health Security Donates ATNAA to Ukraine Through the European Commission's rescEU and Governmental Strategic Reserves Agency (RARS)

Innovation in Abu Dhabi: The Venom Blockchain Revolution Begins

Diamyd Medical enters into equity financing agreements with new U.S. sector specialist investors for up to USD 125 million and announces full enrollment in Phase 3 trial

PR Newswire associated0

Proteotype Awarded £1.5 Million Grant to Advance Early Cancer Detection with Innovative Enlighten® Test